According to data compiled by Verified Market Intelligence, the global cannabis market was valued at USD 42.2 Billion in 2017 and is expected to reach USD 466.81 Billion by 2025. The market is also set to grow at a CAGR of 35.3% during the period. The strong growth rate for the market is attributable to the widespread legalization of medical and recreational cannabis. Many nations are adopting medical cannabis treatment for therapeutic reasons, while some are exploring opportunities within the recreational market. The North American region had dominated the cannabis market last year, controlling 95% of the market value, as the U.S. alone drove in 90% of the revenue. Micron Waste Technologies Inc. (OTC: MICWF), KushCo Holdings, Inc. (OTC: KSHB), Emerald Health Therapeutics Inc.

With the legalization of cannabis in Canada and nine U.S. states, the marijuana industry is wide open, but marketing the product still comes with its problems.

Canada has strict rules on branding—the packaging must be generic and informational with mandatory labels. There are even restrictions on colors.

When the curtain closes on 2018 in roughly eight weeks, it's likely to go down as the most monumental year on record for the legal cannabis industry. Though there have been major advances before -- including California becoming the first state to legalize medical marijuana in 1996 and Uruguay becoming the first country in the world to legalize recreational marijuana -- arguably nothing beats Canada's decision to legalize recreational marijuana in 2018.

His net worth stands at close to $3.2 billion, according to Forbes. He became a legend at Goldman Sachs, helping build the firm's asset management business into a giant in the industry. He founded and ran one of the most successful hedge funds in the world. And now Leon Cooperman is investing his personal money in marijuana stocks.

CBD has long been a consistent performer of the overall cannabis market as industry leaders have enjoyed the flexibility of loopholes surrounding legalities, as well as a rising consumer sentiment toward alternative health options. CBD-infused products have allowed companies to expand into a variety of industries and continue to generate higher and higher revenues. The hemp-derived CBD market is projected to top $590 million in revenue, according to the Brightfield Group. The industry will continue growing as it matures, and is also expected to receive a boost if legislation removes CBD as a controlled substance in the near future. Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), MariMed Inc.

Amid all the ruckus of 2018 an investing thesis has emerged that has taken Wall Street by storm: Marijuana stocks surged almost like bitcoin did in its heyday.

There was extreme exuberance stemming from the legalization of pot in Canada and marijuana stocks like Canopy Growth (NYSE:CGC) and Tilray(NASDAQ:TLRY) were rocket ships that seemed unstoppable. TLRY especially was a short stock nightmare as it became difficult to trade even through options. I was lucky enough to ride perfectly through long calls and short puts and it was still tough to fill my winning orders.

The big drop in the share prices of marijuana stocks in recent weeks has investors trying to decide if this is the best time to buy their favourite cannabis stock.

Let’s take a look at HEXO (TSX:HEXO) and Tilray (NASDAQ:TLRY) to see if one deserves to be in your portfolio today.

Canada has a challenger to its status as the pot-stock capital of the world — the scrappy over-the-counter market in the U.S.

There are now 136 cannabis-related securities on OTC Markets Group Inc.’s main and venture market. That compares with 144 companies on Canadian exchanges.

Today we have uncovered three Canadian marijuana stocks trading at low 12-month forward Enterprise Value to Sales ratios.

All the companies we have selected trade below 4x EV/Sales, potentially offering investors a better value play. For comparison, Canopy Growth Corp. (TSX:WEED) trades at a 12-month forward EV/Sales multiple of 22x, while Aphria trades at a multiple of 13x. As such, for investors looking for value in an industry plagued with high valuations, these companies may be a good place to start. Note: All metrics reflect closing prices as at November 1, 2018.

https://www.benzinga.com/markets/cannabis/18/11/12585853/what-legal-cannabis-means-for-canadas-economy

Canada is buzzing after the legalization of recreational cannabis, with long lines at the few retailers already open, a supply shortage, impaired driving fears, people taking to the streets in joy ... 

But what does legalization mean for the Canadian economy? How much is the market potentially worth?